Company's retail presence grows to 56 locations in Florida and 146 nationwide; two new flavors of BlueKudu chocolate products launching statewide on January 13

NEW YORK, Jan. 12, 2023 /CNW/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of its Palm Beach Gardens dispensary as well as the expansion of BlueKudu infused chocolate flavors available on Florida retail menus.

Located near Palm Beach Gardens at 3540 Northlake Blvd., West Palm Beach, FL 33403, the new 4,500 sq. ft. dispensary opens its doors to patients on Friday, January 13 at 9:00 a.m., with ongoing operating hours of 9:00 a.m. to 8:30 p.m. Monday through Saturday and 10:00 a.m. to 7:00 p.m. on Sunday. A grand opening celebration is planned for Friday, January 20, and will commence with a ribbon cutting at 10:00 a.m. followed by festivities throughout the day including swag giveaways, games, prizes and local vendors.

Beginning on Friday, January 13, Florida patients will have access to two new flavors of BlueKudu artisanal infused chocolates: espresso dark chocolate and caramel milk chocolate. Both flavors will be available for preorder online, in-store, and via statewide delivery.

"We are thrilled to continue expanding access to medical cannabis for Florida's growing patient population and to bring more premium edibles to the state with our new BlueKudu products," said Matt Darin, CEO of Curaleaf. "We look forward to welcoming patients in the Palm Beach area with an unrivaled retail experience and the high-quality, trusted cannabis products they can rely on." 

Curaleaf Palm Beach Gardens is dedicated to providing high-quality cannabis products and service to patients at all stages of their cannabis journey. The new location offers a broad selection of premium cannabis products, including high-quality flower and pre-rolls, BlueKudu Chocolate, Select Squeeze, Select X-Bites, Select Elite, Elite Live and Live Rosin vape cartridges, as well as other concentrates by Curaleaf.  

For more information on Curaleaf's locations, patient resources and products in Florida, please visit: https://curaleaf.com/dispensary/florida. 

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 21 states with 146 dispensaries, 29 cultivation sites, and employs nearly 6,000 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.  

This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the opening of Curaleaf Northlake in Palm Beach Gardens. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed March 9, 2022, which is available under the Company's SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.  

INVESTOR CONTACT  
Curaleaf Holdings, Inc.  
Camilo Lyon, Chief Investment Officer  
This email address is being protected from spambots. You need JavaScript enabled to view it.  

MEDIA CONTACT  
Curaleaf Holdings, Inc.  
Tracy Brady, SVP Corporate Communications  
This email address is being protected from spambots. You need JavaScript enabled to view it.